The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family.

Cytochrome P450 (CYP) adverse drug reactions (ADRs) carcinogens drug-metabolizing enzymes (DMEs) metabolism toxicology xenobiotic

Journal

Journal of xenobiotics
ISSN: 2039-4713
Titre abrégé: J Xenobiot
Pays: Switzerland
ID NLM: 101701430

Informations de publication

Date de publication:
22 Jun 2021
Historique:
received: 10 05 2021
revised: 14 06 2021
accepted: 16 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

Human Cytochrome P450 (CYP) enzymes constitute a superfamily of membrane-bound hemoproteins that are responsible for the metabolism of a wide variety of clinically, physiologically, and toxicologically important compounds. These heme-thiolate monooxygenases play a pivotal role in the detoxification of xenobiotics, participating in the metabolism of many structurally diverge compounds. This short-review is intended to provide a summary on the major roles of CYPs in Phase I xenobiotic metabolism. The manuscript is focused on eight main topics that include the most relevant aspects of past and current CYP research. Initially, (I) a general overview of the main aspects of absorption, distribution, metabolism, and excretion (ADME) of xenobiotics are presented. This is followed by (II) a background overview on major achievements in the past of the CYP research field. (III) Classification and nomenclature of CYPs is briefly reviewed, followed by (IV) a summary description on CYP's location and function in mammals. Subsequently, (V) the physiological relevance of CYP as the cornerstone of Phase I xenobiotic metabolism is highlighted, followed by (VI) reviewing both genetic determinants and (VI) nongenetic factors in CYP function and activity. The last topic of the review (VIII) is focused on the current challenges of the CYP research field.

Identifiants

pubmed: 34206277
pii: jox11030007
doi: 10.3390/jox11030007
pmc: PMC8293344
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

94-114

Subventions

Organisme : Fundação para a Ciência e a Tecnologia
ID : UID/BIM/0009/2020

Références

Front Pharmacol. 2017 Oct 30;8:755
pubmed: 29163152
EMBO Rep. 2009 Jul;10(7):742-7
pubmed: 19483672
Biochem Biophys Res Commun. 1968 Mar 27;30(6):607-12
pubmed: 5642380
Toxicol In Vitro. 2020 Feb;62:104681
pubmed: 31655123
Hepatology. 2000 Jul;32(1):49-55
pubmed: 10869288
Biochem Biophys Res Commun. 1974 Sep 9;60(1):8-14
pubmed: 4472879
Annu Rev Pharmacol Toxicol. 1994;34:135-72
pubmed: 8042848
Chem Commun (Camb). 2019 Nov 18;55(89):13422-13425
pubmed: 31638629
Biochem Z. 1963;338:741-55
pubmed: 14087340
J Pharmacol Exp Ther. 2000 Aug;294(2):524-30
pubmed: 10900228
Curr Drug Targets. 2018;19(1):38-54
pubmed: 28124606
Drug Metab Dispos. 2012 Jan;40(1):83-92
pubmed: 21994437
J Biol Chem. 1975 May 10;250(9):3567-70
pubmed: 1123353
Annu Rev Med. 2006;57:119-37
pubmed: 16409140
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1764-73
pubmed: 18628430
Biochem Biophys Res Commun. 1967 Nov 30;29(4):521-6
pubmed: 16496529
Proc Natl Acad Sci U S A. 1983 Jul;80(13):3958-62
pubmed: 6306654
Pharmacol Rev. 1967 Sep;19(3):317-66
pubmed: 4383307
Biochem Pharmacol. 2000 Aug 1;60(3):293-306
pubmed: 10856424
Biochem Pharmacol. 2003 Dec 15;66(12):2333-40
pubmed: 14637191
Biochem Pharmacol. 2004 Oct 1;68(7):1371-81
pubmed: 15345327
Hum Genomics. 2009 Oct;4(1):59-65
pubmed: 19951895
Xenobiotica. 1989 Oct;19(10):1149-60
pubmed: 2683414
Curr Drug Metab. 2006 Jan;7(1):23-37
pubmed: 16454691
Drug Metab Rev. 2016 Aug;48(3):331-41
pubmed: 27440109
Prog Mol Biol Transl Sci. 2012;112:31-88
pubmed: 22974737
Mol Pharmacol. 1967 Mar;3(2):113-23
pubmed: 4382749
Pharmacogenomics. 2004 Oct;5(7):895-931
pubmed: 15469410
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):52-6
pubmed: 15993453
Drug Metab Pharmacokinet. 2011;26(1):15-29
pubmed: 20978360
Int Rev Cytol. 2007;260:35-112
pubmed: 17482904
Clin Pharmacol Ther. 2000 Jan;67(1):32-43
pubmed: 10668851
Arch Biochem Biophys. 2012 Nov 1;527(1):16-22
pubmed: 22885143
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Curr Drug Metab. 2009 Jun;10(5):508-19
pubmed: 19689247
Arch Biochem Biophys. 1958 Jun;75(2):376-86
pubmed: 13534720
Environ Health Perspect. 1998 Oct;106(10):633-41
pubmed: 9755138
Nat Rev Drug Discov. 2002 Apr;1(4):259-66
pubmed: 12120277
J Pharmacol Exp Ther. 2011 Apr;337(1):125-36
pubmed: 21205922
Naunyn Schmiedebergs Arch Pharmacol. 2006 Mar;372(6):465-75
pubmed: 16532306
Curr Top Med Chem. 2013;13(12):1429-40
pubmed: 23688133
Clin Pharmacol Ther. 2006 May;79(5):480-8
pubmed: 16678549
Int J Mol Sci. 2020 Sep 11;21(18):
pubmed: 32933097
Clin Liver Dis. 2017 Feb;21(1):1-20
pubmed: 27842765
FASEB J. 1992 Jan 6;6(2):759-64
pubmed: 1537466
J Biol Chem. 1963 Apr;238:1320-3
pubmed: 14022832
Nature. 2003 Jul 24;424(6947):464-8
pubmed: 12861225
Hum Mutat. 2010 Jan;31(1):27-40
pubmed: 19802894
Biochem Soc Trans. 2018 Oct 19;46(5):1213-1224
pubmed: 30287511
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5597-601
pubmed: 1829523
Mol Pharmacol. 2004 Feb;65(2):326-34
pubmed: 14742674
Mol Pharmacol. 2006 Jun;69(6):1924-30
pubmed: 16505155
Drug Metab Dispos. 2011 Feb;39(2):191-8
pubmed: 21045201
J Biol Chem. 2006 Mar 17;281(11):7614-22
pubmed: 16352597
Fundam Clin Pharmacol. 2007 Oct;21(5):467-80
pubmed: 17868200
Drug Metab Rev. 2003 May-Aug;35(2-3):99-106
pubmed: 12959412
J Pharmacol Exp Ther. 2004 Aug;310(2):571-7
pubmed: 15075384
Basic Clin Pharmacol Toxicol. 2009 Jul;105(1):24-9
pubmed: 19371259
JHEP Rep. 2020 Sep 03;3(1):100177
pubmed: 33294829
Pharmacogenet Genomics. 2015 Aug;25(8):416-26
pubmed: 26049587
Biochem Pharmacol. 2010 Jan 15;79(2):261-9
pubmed: 19682433
Annu Rev Biochem. 1987;56:945-93
pubmed: 3304150
Biochem Pharmacol. 1999 Apr 15;57(8):951-4
pubmed: 10086330
Mol Pharmacol. 2003 May;63(5):1180-9
pubmed: 12695546
Cancer Treat Rev. 2015 Dec;41(10):935-50
pubmed: 26585358
Int J Mol Sci. 2018 Dec 06;19(12):
pubmed: 30563285
Cancer Res. 2006 Sep 15;66(18):9090-8
pubmed: 16982751
Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):861-73
pubmed: 19505191
Drug Metab Rev. 2016 Nov;48(4):473-501
pubmed: 27533622
J Biotechnol. 2006 Jun 25;124(1):128-45
pubmed: 16516322
J Mol Biol. 1987 Jun 5;195(3):687-700
pubmed: 3656428
Biochem Pharmacol. 2010 Apr 1;79(7):1045-52
pubmed: 19945440
J Biochem Mol Toxicol. 2007;21(4):176-81
pubmed: 17936931
Drug Metab Dispos. 2015 Mar;43(3):400-10
pubmed: 25519488
J Biol Chem. 2007 May 11;282(19):14348-55
pubmed: 17311915
Cell. 2006 Jan 13;124(1):35-46
pubmed: 16413480
Curr Drug Metab. 2009 Jul;10(6):567-78
pubmed: 19702536
Drug Metab Rev. 2014 Aug;46(3):261-82
pubmed: 24483608
Annu Rev Pharmacol Toxicol. 2012;52:37-56
pubmed: 21819238
Drug Metab Dispos. 2007 Oct;35(10):1935-41
pubmed: 17646279
Adv Exp Med Biol. 2015;851:247-97
pubmed: 26002739
Annu Rev Pharmacol. 1972;12:57-84
pubmed: 4114185
Pharmacogenet Genomics. 2013 Feb;23(2):41-52
pubmed: 23295917
Clin Pharmacol Ther. 2009 Apr;85(4):434-8
pubmed: 19212314
J Biol Chem. 2003 Apr 18;278(16):14146-52
pubmed: 12571232
J Biol Chem. 1985 Jul 25;260(15):9057-67
pubmed: 4019462
Chem Res Toxicol. 2012 Jul 16;25(7):1316-83
pubmed: 22531028
Pharmacol Ther. 2007 Dec;116(3):496-526
pubmed: 18001838
Chem Res Toxicol. 2015 Jan 20;28(1):38-42
pubmed: 25485457
Front Microbiol. 2015 Sep 17;6:948
pubmed: 26441882
Chem Res Toxicol. 2019 Dec 16;32(12):2466-2478
pubmed: 31730751
Biochem Mol Biol Educ. 2006 Mar;34(2):66-74
pubmed: 21638641
J Biol Chem. 1968 Jun 25;243(12):3543-6
pubmed: 4297783
Science. 2007 Feb 9;315(5813):848-53
pubmed: 17289997
Arch Biochem Biophys. 2005 Jan 15;433(2):369-78
pubmed: 15581593
Biochem Biophys Res Commun. 2005 Dec 9;338(1):507-19
pubmed: 16246311
BMC Genomics. 2006 Jul 19;7:181
pubmed: 16854234
J Biol Chem. 1999 Mar 5;274(10):6043-6
pubmed: 10037683
Biochem Biophys Res Commun. 2014 Mar 7;445(2):404-11
pubmed: 24530915
Bioinformatics. 2011 Sep 15;27(18):2473-7
pubmed: 21757465
Acta Pharm Sin B. 2020 Jan;10(1):19-32
pubmed: 31998605
Drug Metab Dispos. 2012 Jul;40(7):1366-79
pubmed: 22496397
Methods Mol Biol. 1998;107:15-24
pubmed: 14577209
Adv Pharmacol. 2015;74:1-33
pubmed: 26233902
J Biol Chem. 1985 Dec 25;260(30):16122-30
pubmed: 4066706
Pharmacol Rev. 2018 Apr;70(2):384-411
pubmed: 29514871
Biochim Biophys Acta. 2015 Apr;1850(4):696-707
pubmed: 25529298
Drug Metab Dispos. 2016 Feb;44(2):262-74
pubmed: 26586378
Philos Trans R Soc Lond B Biol Sci. 2013 Jan 06;368(1612):20120431
pubmed: 23297354
Rev Environ Health. 1974;1(4):261-82
pubmed: 4617260
J Pharmacol Exp Ther. 2006 Nov;319(2):693-702
pubmed: 16857725
Trends Pharmacol Sci. 2016 Aug;37(8):625-640
pubmed: 27267697
J Biol Chem. 2004 Sep 10;279(37):38091-4
pubmed: 15258162
Mol Pharmacol. 2010 Oct;78(4):608-16
pubmed: 20631054
Arch Toxicol. 2008 Oct;82(10):667-715
pubmed: 18618097
Toxicol Sci. 2011 Mar;120(1):1-13
pubmed: 21149643
J Biol Chem. 1962 Apr;237:1375-6
pubmed: 14482007
Curr Drug Metab. 2015;16(10):850-63
pubmed: 26652254
J Biol Chem. 1948 Nov;176(2):535-44
pubmed: 18889911
Biochim Biophys Acta. 2011 Jan;1814(1):14-8
pubmed: 20736090
Mutat Res. 1999 Apr 26;441(1):73-83
pubmed: 10224324
Toxicol Appl Pharmacol. 2006 Oct 1;216(1):1-10
pubmed: 16712892
Biochem Biophys Res Commun. 1978 Mar 15;81(1):154-60
pubmed: 656092
Mol Psychiatry. 2013 Mar;18(3):273-87
pubmed: 22565785
J Gastroenterol Hepatol. 2009 Jun;24(6):1038-44
pubmed: 19638083
DNA. 1987 Feb;6(1):1-11
pubmed: 3829886
J Biol Chem. 2009 Apr 24;284(17):11374-84
pubmed: 19171935
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2545-8
pubmed: 6941308
J Biol Chem. 1991 Oct 15;266(29):19186-91
pubmed: 1918035
Mutagenesis. 1998 May;13(3):263-9
pubmed: 9643585
Basic Life Sci. 1975;6:207-71
pubmed: 808210
Arch Biochem Biophys. 1958 Oct;77(2):493-509
pubmed: 13584011
J Inorg Biochem. 2018 Sep;186:264-266
pubmed: 29990750
J Steroid Biochem Mol Biol. 2015 Jul;151:66-73
pubmed: 25446886
J Biol Chem. 2009 Dec 25;284(52):36628-36637
pubmed: 19858215
Toxicol Res. 2016 Apr;32(2):89-93
pubmed: 27123158
Front Pharmacol. 2017 Aug 25;8:580
pubmed: 28970799
Chem Res Toxicol. 2008 Jan;21(1):70-83
pubmed: 18052394
Cancer Res. 2003 Dec 15;63(24):8623-8
pubmed: 14695173
Science. 1993 Aug 6;261(5122):731-6
pubmed: 8342039
Br J Pharmacol. 2017 Jul;174(13):1908-1924
pubmed: 28299773
J Biol Chem. 1991 Apr 25;266(12):7321-4
pubmed: 2019566
Clin Cancer Res. 2006 Dec 15;12(24):7492-7
pubmed: 17189422
Pharmacogenomics. 2010 May;11(5):625-7
pubmed: 20415549
Biochim Biophys Acta. 2007 Mar;1770(3):314-29
pubmed: 17239540
Mutagenesis. 2005 May;20(3):217-28
pubmed: 15843387
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):38-50
pubmed: 27068427
Drug Metab Dispos. 2009 Oct;37(10):2112-7
pubmed: 19581388
Drug Metab Dispos. 2003 Dec;31(12):1461-73
pubmed: 14625342
Front Pharmacol. 2020 Mar 18;11:299
pubmed: 32256365
Cancer Res. 1983 Oct;43(10):4752-6
pubmed: 6411332
Front Genet. 2012 Oct 10;3:206
pubmed: 23087703
Mol Pharmacol. 2005 Jun;67(6):2088-101
pubmed: 15778453
Drug Metab Dispos. 2017 Apr;45(4):375-389
pubmed: 28188297
J Biol Chem. 1968 Mar 25;243(6):1331-2
pubmed: 4385007
Drug Metab Dispos. 2015 May;43(5):774-85
pubmed: 25739975
Biochem Biophys Res Commun. 1999 Dec 29;266(3):690-8
pubmed: 10603307
Nature. 2019 Jun;570(7762):462-467
pubmed: 31158845
Protein Expr Purif. 2002 Apr;24(3):329-37
pubmed: 11922748
Mutagenesis. 2007 Jan;22(1):75-81
pubmed: 17158518
Mutat Res. 2019 Oct;846:503094
pubmed: 31585631
Mutat Res. 1983 May;113(3-4):173-215
pubmed: 6341825
Mol Pharmacol. 1969 Mar;5(2):186-99
pubmed: 5787085

Auteurs

Francisco Esteves (F)

Center for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Huma Toxicology, NOVA Medical School/Faculty of Medical Sciences, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.

José Rueff (J)

Center for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Huma Toxicology, NOVA Medical School/Faculty of Medical Sciences, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.

Michel Kranendonk (M)

Center for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Huma Toxicology, NOVA Medical School/Faculty of Medical Sciences, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.

Classifications MeSH